Zobrazeno 1 - 10 of 78 pro vyhledávání: '"B. de la Lande"'
1
Abstract P3-12-06: TOxicities of Locoregional Radiotherapy Associated with Bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
Autor: PH Cottu, C. Levy, A Gobillion, K Peignaux, B. De La Lande, A. Clément-Zhao, C. Lemanski, P. Bontemps, M-L Tanguy, A Reynaud-Bougnoux, Y.M. Kirova, P Baumann
Publikováno v: Cancer Research. 79:P3-12
Background and Purpose: Recent phase 3 clinical trials have evaluated the addition of bevacizumab (B) to standard chemotherapy in the treatment of patients with non-metastatic breast cancer. But few data are available about the tolerance of B with lo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a301ed8231885fc8b7bcdc1ff3726c6
https://doi.org/10.1158/1538-7445.sabcs18-p3-12-06
Zobrazit plný text záznamu
2
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study
Autor: F. Denis, B. De La Lande, P Baumann, C. Lemanski, P. Bontemps, V. Pernin, Paul-Henri Cottu, Lisa Belin, Christine Levy, F. Missohou, A Reynaud-Bougnoux, A Gobillion, Y.M. Kirova, A. Dautruche, K Peignaux
Publikováno v: Cancer/Radiothérapie. 22:222-228
Purpose To determine the 3 years late toxicity among patients with non-metastatic breast cancer who received concurrent bevacizumab and locoregional radiotherapy. Material and methods This is a single-arm, multicentre, prospective study, of the toxic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e2161494662959e13c78a4160bd7fb
https://doi.org/10.1016/j.canrad.2017.10.004
Zobrazit plný text záznamu
4
Abstract P1-10-17: Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer
Autor: Y.M. Kirova, PH Cottu, A. Dautruche, C. Lemanski, P. Bontemps, P Baumann, Christine Levy, F. Missohou, A Reynaud-Bougnoux, Alain Fourquet, Lisa Belin, K Peignaux, B. De La Lande, A Gobillion, N Ady Vago, F. Denis
Publikováno v: Cancer Research. 77:P1-10
Purpose/Objectives The purpose of this study was to determine early and late toxicities among patients with non-metastatic breast cancer (BC) receiving concurrent bevacizumab (BV) and radiation therapy (RT). Materials/Methods Multicentre, prospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a9f213df0d07e50d2660d75c83f3c49
https://doi.org/10.1158/1538-7445.sabcs16-p1-10-17
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
[Spinal stereotactic body radiotherapy: French assessment in 2016]
Autor: I, Pougnet, E, Jaegle, R, Garcia, F, Tessier, J C, Faivre, G, Louvel, E, Gross, L, Gonzague, M, Benchalal, A, Ducteil, S, Supiot, D, Autret, J B, Clavier, X, Mirabel, A, Bellière, D, Wdowczyk, S, Heymann, I, Barillot, B, de La Lande, V, Passerat, M P, Sunyach, F, Lipinski, D, Thibouw, F, Guichard, B, Chauvet, J, Thariat, A, Arnaud
Publikováno v: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 21(4)
Stereotactic body radiotherapy to vertebral column remains uncommon practice and only relevant in selected group of patients. The main objective of the study was to describe the current state of medical practices of stereotactic body radiotherapy to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8e137e1e0637fa19532a50637a9f9e11
https://pubmed.ncbi.nlm.nih.gov/28499659
Zobrazit plný text záznamu
9
Abstract P3-06-19: Large-scale retrospective analysis between 1980-2008 in 20 838 women with breast cancer - Results in young women (< 40 years old)
Autor: L. Jouanneau, Florence Lerebours, J.-M. Guinebretiere, A. Guerard, Catherine Noguès, D. Stevens, Emmanuelle Mouret-Fourme, Pascal Cherel, S. Lasry, B. De La Lande
Publikováno v: Cancer Research. 73:P3-06
Background: The risk for developing breast cancer before the age of 40 is less than 1% and is similar worldwide. Breast cancer in young women is different from that of older women in terms of clinical and pathological characteristics and prognosis. W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c642a0a7691b55d82c268937055dbbc3
https://doi.org/10.1158/0008-5472.sabcs13-p3-06-19
Zobrazit plný text záznamu
10
Abstract P5-14-11: Locoregional toxicities after adjuvant radiotherapy with or without concurrent bevacizumab in patients with non-metastatic breast cancer
Autor: V-E Pernin, Lisa Belin, A Gobillion, C. Lemanski, P. Bontemps, F. Denis, B. De La Lande, Christelle Levy, K Peignaux, P Baumann, Philippe Bougnoux, F. Missohou, PH Cottu, Y.M. Kirova
Publikováno v: Cancer Research. 73:P5-14
Purpose/Objectives Few data are available regarding the safety of the concurrent combination of bevacizumab with adjuvant radiotherapy (RT) in breast cancer, especially in terms of late toxicity. The aim of this study was to determine early and late
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e41c2c8032abbfdb74f10c1531c03ef6
https://doi.org/10.1158/0008-5472.sabcs13-p5-14-11
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje